Guardant Health GH Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Guardant Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Guardant Health's cash & equivalents?
- Guardant Health (GH) reported cash & equivalents of $1.1B in Q1 2026.
- How has Guardant Health's cash & equivalents changed year-over-year?
- Guardant Health's cash & equivalents increased by 37.0% year-over-year, from $803.85M to $1.1B.
- What is the long-term trend for Guardant Health's cash & equivalents?
- Over 5 years (2020 to 2025), Guardant Health's cash & equivalents has grown at a -10.1% compound annual growth rate (CAGR), from $832.98M to $489.42M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.